glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated Clinical Use of Inhibitors Drug mechanism of action of

Moreover, the review emphasizes the therapeutic potential of GLP-1RAs in specific disease contexts like type 2 diabetes, a neurodegenerative disorder, and inflammatory bowel disease (IBD), shedding light on their anti-inflammatory effects through rigorous examination of preclinical and clinical studies

A case of morbilliform drug eruption to dulaglutide

Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor

In our assay, we employ the HTRF cAMP Gs HiRange detection kit from Revvity as the readout for the measurement of the cAMP levels produced upon GLP1 receptor activation

With hindsight, these findings reflected the importance of DPP-4 for the degradation of GLP-2, more evident in rats than in mice